Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria
- PMID: 2846422
- DOI: 10.1016/s0046-8177(88)80290-9
Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria
Abstract
Fifty-three cases of mammary carcinoma originally diagnosed as medullary carcinoma (MC) or infiltrating duct carcinoma (IDC) with medullary features were reviewed and reclassified using the strictly defined histologic criteria applied a decade ago by Ridolfi et al. Our study interval (1961 to 1982) allowed for a minimum follow-up of 5 years for each patient, with a mean follow-up period of 7.2 years. When reclassified, 24 tumors fulfilled the criteria for MC, 16 tumors were determined to be atypical MC, and ten tumors were found to be IDC; the observed 5-year survival rates were 95%, 80%, and 70%, respectively. These findings confirmed those of other investigators, that when specific criteria are applied, MC proves to be a form of mammary carcinoma with a favorable prognosis. However, we also found that when tumors were excluded from the MC category solely on the basis of in situ carcinoma, focal marginal infiltration, or a sparse mononuclear infiltrate, the survival rate of these patients was similar to that of patients in the medullary category. Thus, we propose that one of these criteria alone should not suffice to exclude the diagnosis of MC. On the other hand, tumors with two or more of these atypical features, or with extensive marginal infiltration, no mononuclear cellular infiltrate, and/or less than 75% syncytial growth, should be classified as IDC with medullary features. Typical MC with bland nuclei or a focal microglandular growth pattern only were not observed in this series; however, these findings should probably also cause a tumor to be classified in the IDC category. By dividing our cases into two rather than three groups, we found a statistically significant difference between the survival rates of 94% and 64% for MC (34 tumors) and IDC (14 tumors), respectively. Although the latter figure probably exceeds the survival rate for IDC without medullary features, the difference does not appear great enough to warrant a separate diagnostic category.
Similar articles
-
Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.Eur J Cancer. 1995 Dec;31A(13-14):2289-95. doi: 10.1016/0959-8049(95)00408-4. Eur J Cancer. 1995. PMID: 8652258
-
Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.Mod Pathol. 1995 Jan;8(1):31-8. Mod Pathol. 1995. PMID: 7731939
-
Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma.Cancer. 1988 Jun 15;61(12):2503-10. doi: 10.1002/1097-0142(19880615)61:12<2503::aid-cncr2820611219>3.0.co;2-3. Cancer. 1988. PMID: 2835145
-
HER2 as a prognostic factor in breast cancer.Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
-
[Medullary carcinoma of the breast. What remains of this entity today?].Arch Anat Cytol Pathol. 1995;43(1-2):44-50. Arch Anat Cytol Pathol. 1995. PMID: 7794026 Review. French.
Cited by
-
Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.Am J Pathol. 1990 Nov;137(5):1059-64. Am J Pathol. 1990. PMID: 2173410 Free PMC article.
-
From Statistics to Stories: Unveiling the Epidemiology of Breast Carcinoma in Northwestern India.Indian J Surg Oncol. 2025 Apr;16(2):543-549. doi: 10.1007/s13193-024-02104-8. Epub 2024 Sep 30. Indian J Surg Oncol. 2025. PMID: 40337059
-
Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray.Singapore Med J. 2022 Jul;63(7):394-401. doi: 10.11622/smedj.2021031. Epub 2021 Apr 16. Singapore Med J. 2022. PMID: 33866710 Free PMC article.
-
Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features.Br J Cancer. 1991 Apr;63(4):591-5. doi: 10.1038/bjc.1991.137. Br J Cancer. 1991. PMID: 2021545 Free PMC article.
-
Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.Am J Pathol. 1990 Dec;137(6):1299-304. Am J Pathol. 1990. PMID: 1701960 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical